PRGO

Perrigo Company plc

$16.83

-0.71%

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Source: Yahoo Finance
AI summary

Price & performance

1M+8.8%
3M+20.8%
YTD+21.1%
1Y+11.4%
52-week range—
Beta0.71
Full chart and returns against a benchmark

Q-Score

45/ 100

Quality against peers; 50 is the peer median.

Growth39
Risk62
Performance36
Valuation63
Profitability47
Leverage35
Sentiment40
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$4.3B-2.8%
Net income-$1.4B
Net margin-33.5%-29.6 pts
Historical fundamentals

Revenue exposure

40%of revenue from outside the US
United States60%
Europe38%
Other Geographical Areas2%
Largest customer13%
Regions, segments, customers and suppliers

Valuation

PRGOIndustryP/E—35.25P/S0.572.74EV/EBITDA—16.35P/B0.962.46PEG—0.87
Dividend yield6.86%
Every valuation metric

Earnings

Nov 4next report, before the open
EPS estimate$0.53
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate